Understanding how certain cells contribute to lung scarring
Novel Mechanisms of Pulmonary Fibrosis
This study is looking at how certain cells in the lungs might contribute to lung scarring in conditions like silicosis, and it’s inviting patients to help by sharing lung tissue samples or joining in related check-ups to help find better treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Cincinnati NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-11088228 on NIH RePORTER |
What this research studies
This research investigates the role of a specific type of cell, known as pulmonary osteoclast-like cells (POLCs), in the development of pulmonary fibrosis, particularly in conditions like silicosis. The study utilizes advanced techniques such as single-cell RNA sequencing to analyze lung tissue and identify how these cells interact with other immune cells in the lungs. By examining the molecular mechanisms involved, the research aims to uncover potential pathways that lead to lung damage and fibrosis, which could inform future treatments. Patients may be able to contribute to this research by providing lung tissue samples or participating in related clinical assessments.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals diagnosed with silicosis or other forms of pulmonary fibrosis.
Not a fit: Patients with pulmonary conditions unrelated to fibrosis or those without a history of exposure to silica may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for preventing or treating pulmonary fibrosis.
How similar studies have performed: Previous research has shown promising results in understanding the role of immune cells in lung diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Cincinnati, United States
- University of Cincinnati — Cincinnati, United States (Active)
Researchers
- Principal investigator: Mccormack, Francis Xavier — University of Cincinnati
- Study coordinator: Mccormack, Francis Xavier
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.